Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012
暂无分享,去创建一个
[1] M. Cappell,et al. A multicenter, case-controlled study of the clinical presentation and etiology of ascites and of the safety and clinical efficacy of diagnostic abdominal paracentesis in HIV seropositive patients. , 1994, The American journal of gastroenterology.
[2] H. Shalaby,et al. Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites. , 2009, World journal of gastroenterology.
[3] S. J. Park,et al. Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites. , 2001, Journal of vascular and interventional radiology : JVIR.
[4] M. Bilodeau,et al. Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease , 2005, Alimentary pharmacology & therapeutics.
[5] P. Kamath,et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. , 2003, Gastroenterology.
[6] J. Rundback,et al. Peritoneal-urinary drainage for treatment of refractory ascites: a pilot study. , 1998, Journal of vascular and interventional radiology : JVIR.
[7] A. Lok,et al. Outcomes of patients with chest tube insertion for hepatic hydrothorax , 2009, Hepatology international.
[8] R. Fontana,et al. Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracentesis , 1999, American Journal of Gastroenterology.
[9] D. Rubinstein,et al. Hepatic hydrothorax in the absence of clinical ascites: diagnosis and management. , 1985, Gastroenterology.
[10] J. C. Hernandez,et al. Oral Antibiotic Prophylaxis Reduces Spontaneous Bacterial Peritonitis Occurrence and Improves Short-Term Survival in Cirrhosis: A Meta-Analysis , 2009, The American Journal of Gastroenterology.
[11] B. Runyon,et al. Cellulitis in Patients with Cirrhosis and Edema: An Under-Recognized Complication Currently More Common than Spontaneous Bacterial Peritonitis , 2008 .
[12] D. Decker,et al. Benign and malignant cells in effusions: diagnostic value of image DNA cytometry in comparison to cytological analysis. , 1998, Pathology, research and practice.
[13] E. Schiff,et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites. , 1989, The New England journal of medicine.
[14] S. Ahn,et al. Long‐term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: A randomized prospective study , 2005, Journal of gastroenterology and hepatology.
[15] Eter,et al. A COMPARISON OF PARACENTESIS AND TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNTING IN PATIENTS WITH ASCITES , 2000 .
[16] B. Runyon. Paracentesis of ascitic fluid. A safe procedure. , 1986, Archives of internal medicine.
[17] S. Caldwell,et al. Subumbilical midline vascularity of the abdominal wall in portal hypertension observed at laparoscopy. , 1998, Gastrointestinal endoscopy.
[18] M. Zuckerman,et al. A prospective controlled study of the risk of bacteremia in emergency sclerotherapy of esophageal varices. , 1991, Gastroenterology.
[19] J. Villeneuve,et al. Furosemide‐induced natriuresis as a test to identify cirrhotic patients with refractory ascites , 2001 .
[20] P. Angeli,et al. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites , 1994, Hepatology.
[21] S. Møller. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. , 2010, Journal of hepatology.
[22] B. Runyon. Changing flora of bacterial infections in patients with cirrhosis , 2010, Liver international : official journal of the International Association for the Study of the Liver.
[23] M. Casas,et al. Secondary bacterial peritonitis in cirrhosis: a retrospective study of clinical and analytical characteristics, diagnosis and management. , 2010, Journal of hepatology.
[24] V. Boddi,et al. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. , 2006, World journal of gastroenterology.
[25] G. D’Amico,et al. Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis. , 2005, Gastroenterology.
[26] B. Runyon,et al. Optimization of ascitic fluid culture technique. , 1988, Gastroenterology.
[27] A. Nicolini,et al. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites , 2004, Hepatology.
[28] J. Castellote,et al. Usefulness and complications of thoracentesis in cirrhotic patients. , 2001, The American journal of medicine.
[29] P. Messa,et al. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation. , 2003, Hepato-gastroenterology.
[30] P. Angeli,et al. Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial , 2009, Gut.
[31] A. Albillos,et al. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. , 2005, Journal of hepatology.
[32] T. Poynard,et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta‐analysis , 1999, Hepatology.
[33] P. Angeli,et al. Hyponatremia in cirrhosis: Results of a patient population survey , 2006, Hepatology.
[34] S. Saab,et al. TIPS versus paracentesis for cirrhotic patients with refractory ascites. , 2006, The Cochrane database of systematic reviews.
[35] P. Thuluvath,et al. A vasopressin receptor antagonist (VPA‐985) improves serum sodium concentration in patients with hyponatremia: A multicenter, randomized, placebo‐controlled trial , 2003, Hepatology.
[36] W. Kim,et al. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites , 2003, Hepatology.
[37] Christian Melot,et al. Deleterious effects of beta‐blockers on survival in patients with cirrhosis and refractory ascites , 2010, Hepatology.
[38] T. Starzl,et al. Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. , 1973, The New England journal of medicine.
[39] D. Valla,et al. Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases , 2001, American Journal of Gastroenterology.
[40] F. Wong,et al. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome , 2004, Hepatology.
[41] K. Reddy,et al. Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management , 2006, Hepatology.
[42] P. Kamath,et al. Performance standards for therapeutic abdominal paracentesis , 2004, Hepatology.
[43] J. Llach,et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. , 1988, Gastroenterology.
[44] P. Angeli,et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[45] A. Gimson,et al. Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis. , 1993, Journal of hepatology.
[46] B. Runyon. Ascites and Spontaneous Bacterial Peritonitis , 2011 .
[47] R. Loomba,et al. Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[48] G. Mancia,et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites , 1997, Hepatology.
[49] D. Lebrec,et al. Acute effects of captopril on systemic and renal hemodynamics and on renal function in cirrhotic patients with ascites. , 1985, Gastroenterology.
[50] Shou-Dong Lee,et al. Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites. , 2011, Clinical science.
[51] J. Meunier,et al. Effects of clonidine on diuretic response in ascitic patients with cirrhosis and activation of sympathetic nervous system , 2006, Hepatology.
[52] H. Rousseau,et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. , 2004, Gastroenterology.
[53] M. Merli,et al. Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis , 2003, American Journal of Gastroenterology.
[54] J. Ariza,et al. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. , 2012, Journal of hepatology.
[55] K. McTigue,et al. Reexamining the physical examination for obese patients. , 2011, JAMA.
[56] M. Pavesi,et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study , 2012, Hepatology.
[57] V. Arroyo,et al. Restricted use of albumin for spontaneous bacterial peritonitis , 2007, Gut.
[58] B. Runyon. Malignancy-related ascites and ascitic fluid "humoral tests of malignancy". , 1994, Journal of clinical gastroenterology.
[59] M. Başkol,et al. Five Days of Ceftriaxone to Treat Culture Negative Neutrocytic Ascites in Cirrhotic Patients , 2003, Journal of clinical gastroenterology.
[60] B. Runyon,et al. Choosing the location for non‐image guided abdominal paracentesis , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[61] T. Reynolds,et al. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.
[62] R. Fisher,et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death , 2004, Hepatology.
[63] A. Gerbes,et al. Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity , 2011, Gut.
[64] J. Such,et al. Spontaneous Bacterial Peritonitis , 1997, Seminars in liver disease.
[65] W. Yasmineh,et al. Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States , 1996, Hepatology.
[66] T. Nickolas,et al. Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Mortality and Identifies Acute Kidney Injury in Cirrhosis , 2012, Digestive Diseases and Sciences.
[67] J. Llovet,et al. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. , 1996, Gastroenterology.
[68] B. Runyon. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. , 1986, Gastroenterology.
[69] V. de Lédinghen,et al. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis , 2007, Hepatology.
[70] J. Such,et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. , 1991, Gastroenterology.
[71] P. Thuluvath,et al. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study , 2000, Hepatology.
[72] J. Llach,et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double‐blind, placebo‐controlled trial , 1990, Hepatology.
[73] S. Navaneethan,et al. Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis , 2011, International Urology and Nephrology.
[74] J. Hoefs,et al. Ascitic fluid analysis in malignancy‐related ascites , 1988, Hepatology.
[75] P. Mannucci,et al. Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No , 2006, Journal of thrombosis and haemostasis : JTH.
[76] T. Ganiats,et al. An economic analysis of norfloxacin prophylaxis against spontaneous bacterial peritonitis. , 1997, Journal of hepatology.
[77] P. Brissot,et al. Indication of liver transplantation in severe alcoholic liver cirrhosis: quantitative evaluation and optimal timing. , 2002, Journal of hepatology.
[78] P. Michl. Transjugular Intrahepatic Portosystemic Shunt for Cirrhosis and Ascites: Effects in Patients with Organic or Functional Renal Failure , 2000, Scandinavian journal of gastroenterology.
[79] R. Poupon,et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades , 2004, Hepatology.
[80] S. Mizrahi,et al. Minimally invasive repair of recurrent strangulated umbilical hernia in cirrhotic patient with refractory ascites , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[81] Y. Amoateng-Adjepong,et al. Giant Nonpancreatic Pseudocyst Causing Acute Anuria , 2002, Journal of clinical gastroenterology.
[82] J. Schölmerich,et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis , 1996, Hepatology.
[83] X. Cussó,et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. , 1992, Gastroenterology.
[84] B. Runyon,et al. Natural history of repaired umbilical hernias in patients with and without ascites. , 1985, The American journal of gastroenterology.
[85] J. Vinel,et al. Treatment of Hepatorenal Syndrome as Defined by the International Ascites Club by Albumin and Furosemide Infusion According to the Central Venous Pressure: A Prospective Pilot Study , 2005, The American Journal of Gastroenterology.
[86] V. Arroyo,et al. Compensated cirrhosis: Natural history and prognostic factors , 1987, Hepatology.
[87] J. Llach,et al. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites. , 1990, Gastroenterology.
[88] M. Weston,et al. Dialysis in the treatment of renal failure in patients with liver disease. , 1977, Clinical nephrology.
[89] D. van Duin,et al. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[90] G. Daskalopoulos,et al. Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites. , 1987, Gastroenterology.
[91] S. Walker,et al. Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites. , 1992, Gastroenterology.
[92] D. Pateron,et al. Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage , 1994, Hepatology.
[93] A. Bhalla,et al. Midodrine Versus Albumin in the Prevention of Paracentesis-Induced Circulatory Dysfunction in Cirrhotics: A Randomized Pilot Study , 2008, The American Journal of Gastroenterology.
[94] C. Divino,et al. Complicated hernia presentation in patients with advanced cirrhosis and refractory ascites: management and outcome. , 2010, Surgery.
[95] B. Runyon,et al. Hepatic hydrothorax is a relative contraindication to chest tube insertion. , 1986, The American journal of gastroenterology.
[96] P. Kamath,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.
[97] F. Wong,et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. , 2007, Gastroenterology.
[98] J. Castellví,et al. Spontaneous bacterial empyema in cirrhotic patients: A prospective study , 1996, Hepatology.
[99] M. Navasa,et al. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. , 2007, Gastroenterology.
[100] P. Caraceni,et al. Albumin infusion in patients undergoing large‐volume paracentesis: A meta‐analysis of randomized trials , 2012, Hepatology.
[101] A. Lenaerts,et al. Comparative pilot study of repeated large volume paracentesis vs the combination on clonidine-spironolactone in the treatment of cirrhosis-associated refractory ascites. , 2005, Gastroenterologie clinique et biologique.
[102] E. Christensen,et al. Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome , 2010, Hepatology.
[103] B. Runyon. A pill a day can improve survival in patients with advanced cirrhosis. , 2007, Gastroenterology.
[104] T. Reynolds,et al. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. , 1986, Gastroenterology.
[105] M. Melcher,et al. A novel technique to treat ruptured umbilical hernias in patients with liver cirrhosis and severe ascites. , 2003, Journal of laparoendoscopic & advanced surgical techniques. Part A.
[106] T. Reynolds,et al. Left pleural effusion in patients with chronic liver disease and ascites prospective study of 22 cases , 1981, Digestive Diseases and Sciences.
[107] P. Dykes,et al. Albumin exchange between plasma and ascitic fluid. , 1968, Clinical science.
[108] D. Rimm,et al. Use of magnetic enrichment for detection of carcinoma cells in fluid specimens , 2002, Cancer.
[109] W. Jiménez,et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. , 1987, Gastroenterology.
[110] L. Forni,et al. Continuous hemofiltration in the treatment of acute renal failure. , 1997, The New England journal of medicine.
[111] J. Hoefs,et al. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease. , 1983, The Journal of laboratory and clinical medicine.
[112] Y. Bacq,et al. Ciprofloxacin and long‐term prevention of spontaneous bacterial peritonitis: Results of a prospective controlled trial , 1995, Hepatology.
[113] M. Kumar,et al. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute‐on‐chronic liver failure , 2011, Hepatology.
[114] P. Angeli,et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide , 1999, Hepatology.
[115] T. Reynolds,et al. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit , 2000, American Journal of Gastroenterology.
[116] J. Belghiti,et al. Abdominal wall hernias in the setting of cirrhosis. , 1997, Seminars in liver disease.
[117] B. Sharma,et al. Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo , 2011, European journal of gastroenterology & hepatology.
[118] G. Gasbarrini,et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study , 2007, The Lancet.
[119] C. K. Nain,et al. Terlipressin versus albumin in paracentesis‐induced circulatory dysfunction in cirrhosis: A randomized study , 2006, Journal of gastroenterology and hepatology.
[120] T. Blaschke,et al. Furosemide disposition in cirrhotic patients. , 1981, Gastroenterology.
[121] P. Hillenbrand,et al. Use of Metolazone in the Treatment of Ascites due to Liver Disease , 1971, British medical journal.
[122] M. Pavesi,et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. , 2011, Gastroenterology.
[123] G. Kanel,et al. Glomerular Tubular Reflux‐A Morphologic Renal Lesion Associated with the Hepatorenal Syndrome , 1984, Hepatology.
[124] M. Antillon,et al. Effect of marked peripheral leukocytosis on the leukocyte count in ascites. , 1991, Archives of internal medicine.
[125] K. Reddy,et al. The North American Study for the Treatment of Refractory Ascites. , 2003, Gastroenterology.
[126] D. Yeshurun,et al. Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis , 1999, American Journal of Gastroenterology.
[127] S. Sarin,et al. An Open Label, Pilot, Randomized Controlled Trial of Noradrenaline Versus Terlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response , 2008, The American Journal of Gastroenterology.
[128] C. Mélot,et al. Beta-blockers cause paracentesis-induced circulatory dysfunction in patients with cirrhosis and refractory ascites: a cross-over study. , 2011, Journal of hepatology.
[129] E. H. Ahrens,et al. The effect of rigid sodium restriction in patients with cirrhosis of the liver and ascites. , 1949, The Journal of laboratory and clinical medicine.
[130] M. Pirisi,et al. The Significance of the Furosemide Test for Predicting Ascites Control by Diuretics in Cirrhotics: A Comparison with Volume Expansion and Octreotide Infusion , 2006, Digestive Diseases and Sciences.
[131] T. Berl,et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. , 2006, The New England journal of medicine.
[132] M. Navasa,et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. , 1999, The New England journal of medicine.
[133] P. Ginès,et al. Management of patients with cirrhosis awaiting liver transplantation , 2010, Gut.
[134] Rosa Gilabert,et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems , 1998, Hepatology.
[135] J. McHutchison,et al. The Serum-Ascites Albumin Gradient Is Superior to the Exudate-Transudate Concept in the Differential Diagnosis of Ascites , 1992, Annals of Internal Medicine.
[136] A. Burroughs,et al. Surgical Repair of Umbilical Hernias in Cirrhosis With Ascites , 2011, The American journal of the medical sciences.
[137] B. Runyon. Monomicrobial nonneutrocytic bacterascites: A variant of spontaneous bacterial peritonitis , 1990, Hepatology.
[138] D. Rockey,et al. Hepatic Hydrothorax , 2014, Medicine.
[139] M. Antillon,et al. Ascitic fluid pH and lactate: Insensitive and nonspecific tests in detecting ascitic fluid infection , 1991, Hepatology.
[140] S. Sarin,et al. Terlipressin: An Asset for Hepatologists! , 2011, Hepatology.
[141] R. MacLaren,et al. Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[142] W. Jiménez,et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. , 1996, Gastroenterology.
[143] J. Hoefs,et al. Culture‐Negative Neutrocytic Ascites: A Variant of Spontaneous Bacterial Peritonitis , 1984, Hepatology.
[144] W. Jiménez,et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. , 2012, Journal of hepatology.
[145] A. Workman,et al. A new highly sensitive point of care screen for spontaneous bacterial peritonitis using the leukocyte esterase method. , 2010, Journal of hepatology.
[146] J. Trotter,et al. Incarceration of umbilical hernia following transjugular intrahepatic portosystemic shunt for the treatment of ascites. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[147] A. Saad,et al. METABOLIC STUDIES WITH THE DIURETIC TRIAMTERENE IN PATIENTS WITH CIRRHOSIS AND ASCITES. , 1964, The New England journal of medicine.
[148] E. Keeffe,et al. Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. , 2001, Journal of hepatology.
[149] A. Andrealli,et al. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study. , 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[150] B. Runyon,et al. The efficacy and safety of ɛ‐aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis , 2006, Alimentary pharmacology & therapeutics.
[151] W. Jiménez,et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis , 2005, Hepatology.
[152] P. Ginès,et al. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. , 2010, Journal of hepatology.
[153] K. Brown,et al. Hemorrhagic complications of large volume abdominal paracentesis. , 1996, The American journal of gastroenterology.
[154] C. Yancy,et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. , 2010, JAMA.
[155] R. Moreau,et al. Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: An analysis of 259 episodes , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[156] Gyeong a Kim,et al. Terlipressin and Albumin vs Albumin in Patients with Cirrhosis and Hepatorenal Syndrome: A Randomized Study , 2008 .
[157] G. Everson,et al. Chronic Albumin Infusions to Achieve Diuresis in Patients with Ascites Who Are Not Candidates for Transjugular Intrahepatic Portosystemic Shunt (TIPS) , 2005, Digestive Diseases and Sciences.
[158] V. Arroyo,et al. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. , 2006, Gastroenterology.
[159] J. Kaufman. Care of patients with ascites. , 1994, New England Journal of Medicine.
[160] V. Arroyo,et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. , 1991, The New England journal of medicine.
[161] A. Sonnenberg,et al. Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis. , 1997, Gastroenterology.
[162] Nina Singh,et al. Trimethoprim-Sulfamethoxazole for the Prevention of Spontaneous Bacterial Peritonitis in Cirrhosis , 1995, Annals of Internal Medicine.
[163] V. Vilgrain,et al. Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial , 1996 .
[164] G. Gerken,et al. Which patients benefit from hemodialysis therapy in hepatorenal syndrome? , 2004, Journal of Gastroenterology and Hepatology.
[165] M. Rizzetto,et al. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. , 2007, Journal of hepatology.
[166] H. Kunkel,et al. Electrolyte studies on patients with cirrhosis of the liver. , 1950, The Journal of clinical investigation.
[167] F. Czerwiec,et al. Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. , 2012, Journal of hepatology.
[168] F. Pruvot,et al. Transjugular intrahepatic portosystemic shunt in refractory ascites: a meta‐analysis , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[169] Aniruddha M. Deshpande,et al. Standardized Reporting of Clinical Practice Guidelines: A Proposal from the Conference on Guideline Standardization , 2003, Annals of Internal Medicine.
[170] M. Miquel,et al. Natural history of patients hospitalized for management of cirrhotic ascites. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[171] A. de Gottardi,et al. Risk of complications after abdominal paracentesis in cirrhotic patients: a prospective study. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[172] A. Domingo,et al. Rapid diagnosis of spontaneous bacterial peritonitis by use of Reagent Strips , 2003, Hepatology.
[173] A. Bhalla,et al. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study. , 2012, Journal of hepatology.
[174] R. Andrade,et al. Multicenter hospital study on prescribing patterns for prophylaxis and treatment of complications of cirrhosis , 2002, European Journal of Clinical Pharmacology.
[175] G. Klintmalm,et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. , 1998, Clinical transplantation.
[176] Franz Hackl,et al. Survival in patients undergoing transjugular intrahepatic portosystemic shunt: ePTFE‐covered stentgrafts versus bare stents , 2003, Hepatology.
[177] P. Angeli,et al. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost , 2006, Alimentary pharmacology & therapeutics.
[178] D. Gerber,et al. Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK) , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[179] P. Northup,et al. Mortality after percutaneous endoscopic gastrostomy in patients with cirrhosis: a case series. , 2010, Gastrointestinal endoscopy.
[180] G. McCaughan,et al. Iatrogenic incarceration of umbilical hernia in cirrhotic patients with ascites. , 1995, The American journal of gastroenterology.
[181] J. Cohen,et al. Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis , 1991, Digestive Diseases and Sciences.